Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Multiple Myeloma

Disease Sites:

Not Available

Staging:

Phase III

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Biltibo, Eden

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

06-23-2025

Trial Type:

Treatment

Protocol ID:

VICC-DTCTT23578

National Clinical Trial ID:

NCT06413498

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available